An observational study in Acute Aortic Dissection and Sex Role, sponsored by Shenyang Northern Hospital. Completed. Open to participants aged 21 Years to 89 Years. Per ClinicalTrials.gov, last updated 2017-12-22.
Sponsored by Shenyang Northern Hospital · Observational
The study evaluated the prevalence, presentation, management, and prognosis of coronary heart disease differ according to sex.
The study included 884 patients enrolled in our institute between June 2002 and May 2016. Considering psychosocial factors, treatments, and the outcomes in men versus those in women with acute aortic dissection, explored the association of sex with psychosocial characteristics and mortality risk. Of 884 patients, 211 (23.9%) were women. The median duration of follow-up was 2.9 years (25th -75th percentiles: 1-4 years ).
205 studies on the registry are indexed under Aortic Dissection; 73 are open to participants now.
This study's enrollment of 884 is above the median of 230 across 115 observational studies indexed under Aortic Dissection.
Browse Aortic Dissection studies →Shenyang Northern Hospital is the lead sponsor of 42 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Chinese
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug:Beta-blocker,Angiotensin II receptor blocker,Angiotensin-converting enzyme,Calcium-channel blocker,Aspirin,Statin
Drug: drug · Procedure: Surgery
Drug:Beta-blocker,Angiotensin II receptor blocker,Angiotensin-converting enzyme,Calcium-channel blocker,Aspirin,Statin
Drug: drug · Procedure: Surgery
Application bracket
Also known as: thoracic endovascular aortic repair
Surgery
The outcome measure describes aortic disease-related death，aortic dissection, paraplegia, myocardial ischemia, renal insufficiency and other aortic complications.
The study's primary endpoint during the follow up was the composite of aortic disease-related death, aortic dissection, paraplegia, myocardial ischemia, renal insufficiency and other aortic complications during follow-up.
Time frame: 2.9years
No study locations are listed for this record.
Plan to share: No
This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shenyang Northern Hospital